Nirmatrelvir–ritonavir has been authorized for emergency use by many countries for the treatment of coronavirus disease 2019 (Covid-19). However, the supply falls short of the global demand, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results